1. Sirt3 Exerts Its Tumor-Suppressive Role by Increasing p53 and Attenuating Response to Estrogen in MCF-7 Cells
   Marija Pinterić et al, 2020, Antioxidants CrossRef
2. Mitochondrial sirtuins in stem cells and cancer
   Amit Jaiswal et al, 2022, The FEBS Journal CrossRef
3. Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer
   Mohamed Mokhtar Desouki et al, 2014, Human Pathology CrossRef
4. The Roles of Sirtuin Family Proteins in Cancer Progression
   Erhu Zhao et al, 2019, Cancers CrossRef
5. Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex
   Jun Fan et al, 2014, Molecular Cell CrossRef
6. Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells
   Lian-Xiang Luo et al, 2017, Frontiers in Pharmacology CrossRef
7. A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target
   Yuanyuan Liu et al, 2024, European Journal of Pharmacology CrossRef
8. SirT3 and p53 Deacetylation in Aging and Cancer
   Jijun Chen et al, 2017, Journal of Cellular Physiology CrossRef
9. Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study
   Ishrat Mahjabeen et al, 2016, PLOS ONE CrossRef
10. Mitochondrial sirtuins: Energy dynamics and cancer metabolism
    Hojun Lee et al, 2024, Molecules and Cells CrossRef
11. Sirtuin insights: bridging the gap between cellular processes and therapeutic applications
    Shagufta Kamal et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
12. Expression of SIRT1 and SIRT3 varies according to age in mice
    Youngho Kwon et al, 2015, Anatomy & Cell Biology CrossRef
13. Using mitochondrial sirtuins as drug targets: disease implications and available compounds
    Melanie Gertz et al, 2016, Cellular and Molecular Life Sciences CrossRef
14. The signaling pathways that mediate the anti-cancer effects of caloric restriction
    Yiyi Lu et al, 2019, Pharmacological Research CrossRef
15. Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
    Pavel Jakoube et al, 2021, Cancer Research CrossRef
16. Tumor glycolysis, an essential sweet tooth of tumor cells
    Sumana Paul et al, 2022, Seminars in Cancer Biology CrossRef
17. Uncovering SIRT3 and SHMT2-dependent pathways as novel targets for apigenin in modulating colorectal cancer: In vitro and in vivo studies
    Nourhan M. Abdelmaksoud et al, 2024, Experimental Cell Research CrossRef
18. Mitochondrial sirtuin 3 and various cell death modalities
    Maria A. Yapryntseva et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
19. Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance
    Seong Uk Jeh et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
20. SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells
    Yao Wu et al, 2018, Experimental Cell Research CrossRef
21. Peptide Microarrays for Profiling of Epigenetic Targets
    Antonia Masch et al, 2015, Epigenetic Technological Applications CrossRef
22. LncRNA FENDRR Inhibits Gastric Cancer Cell Proliferation and Invasion via the miR-421/SIRT3/Notch-1 Axis
    Jia Ma et al, 2021, Cancer Management and Research CrossRef
23. Prognostic signature based on mitochondria quality control proteins for the prediction of lung adenocarcinoma patients survival
    Anna S. Gorbunova et al, 2023, Cell Death Discovery CrossRef
24. Sirtuin 3: A Janus face in cancer (Review)
    Yanlu Xiong et al, 2016, International Journal of Oncology CrossRef
25. SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
    Yanlu Xiong et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef
26. SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis
    Huan Liu et al, 2018, Journal of Proteome Research CrossRef
27. The sirtuin family in health and disease
    Qi-Jun Wu et al, 2022, Signal Transduction and Targeted Therapy CrossRef
28. Peptide Microarrays for Epigenetic Targets
    Alexandra Schutkowski et al, 2019, Epigenetic Drug Discovery CrossRef
29. SIRT3 Regulates the ROS-FPR1/HIF-1α Axis under Hypoxic Conditions to Influence Lung Cancer Progression
    Bo Huang et al, 2023, Cell Biochemistry and Biophysics CrossRef
30. SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
    Chiara Lambona et al, 2024, Journal of Medicinal Chemistry CrossRef
31. Role of sirtuins in esophageal cancer: Current status and future prospects
    Ryota Otsuka et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
32. Emerging role of sirtuins in non‑small cell lung cancer (Review)
    Min Zhou et al, 2024, Oncology Reports CrossRef
33. Mitochondrial Sirtuins
    Wen Yang et al, 2018, Introductory Review on Sirtuins in Biology, Aging, and Disease CrossRef
34. Mitochondrial Sirt3 supports cell proliferation by regulating glutamine-dependent oxidation in renal cell carcinoma
    Jieun Choi et al, 2016, Biochemical and Biophysical Research Communications CrossRef
35. Inflammasome: Cancer's friend or foe?
    Michela Terlizzi et al, 2014, Pharmacology & Therapeutics CrossRef
36. Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential
    Jasmine George et al, 2016, Cancer Research CrossRef
37. Role of mitochondrial dysfunction in cancer progression
    Chia-Chi Hsu et al, 2016, Experimental Biology and Medicine CrossRef
38. The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and risk of prostate cancer
    Gaoteng Lin et al, 2024, International Urology and Nephrology CrossRef
39. NAD metabolism in aging and cancer
    John WR Kincaid et al, 2020, Experimental Biology and Medicine CrossRef
40. Mitochondrial Acetylation and Genetic Models of Parkinson's Disease
    Georg Auburger et al, 2014, The Mitochondrion in Aging and Disease CrossRef
41. Role of the mitochondrial stress response in human cancer progression
    Sheng-Fan Wang et al, 2020, Experimental Biology and Medicine CrossRef
42. SIRT3 acts as a novel biomarker for the diagnosis of lung cancer
    Feng Tao et al, 2021, Medicine CrossRef
43. Aberrant expression of SIRT3 is conversely correlated with the progression and prognosis of human gastric cancer
    Bing Yang et al, 2014, Biochemical and Biophysical Research Communications CrossRef
44. Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects
    Mohammad Ebrahimnezhad et al, 2024, Biomedicine & Pharmacotherapy CrossRef
45. A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
    Zhivko Zhelev et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
46. SIRT3 is correlated with the malignancy of non-small cell lung cancer
    Yanlu Xiong et al, 2017, International Journal of Oncology CrossRef
47. The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications
    Shumin Ouyang et al, 2022, Frontiers in Pharmacology CrossRef
48. Post-translational modification of mitochondria as a novel mode of regulation
    Annette Hofer et al, 2014, Experimental Gerontology CrossRef
49. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
    Y Chen et al, 2014, Cell Death & Disease CrossRef
50. SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis
    Rui Guo et al, 2020, Gene CrossRef
51. Role of the Inflammasome in Cancer
    Michela Terlizzi et al, 2020, Cancer Immunology CrossRef
52. The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
    Matthias Schiedel et al, 2018, Medicinal Research Reviews CrossRef
53. ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway
    Zuyi Ma et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
54. Epigenetic Approaches to the Treatment of Renal Cell Cancer
    Seong Hwi Hong et al, 2020, The Korean Journal of Urological Oncology CrossRef
55. Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma
    Serena De Matteis et al, 2017, Digestive Diseases and Sciences CrossRef
56. Low SIRT3 expression contributes to tumor progression, development and poor prognosis in human pancreatic carcinoma
    Shanshan Huang et al, 2017, Pathology - Research and Practice CrossRef
57. Roles of sirtuins in asthma
    Yahui Liu et al, 2022, Respiratory Research CrossRef